origin of glp 1 drugs The GLP-1 revolution: What UAB researchers are discovering about how these work Discovery of GLP-1–Based Drugs for

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Novo Nordisk (the maker

We already know that GLP-1s act on the brain in various ways

Enriched with Decaffeinated Green Tea Leaf Extract, standardized to 50% EGCG, and Gymnema Sylvestre Leaf Extract

In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)

Direct-to-consumer health and wellness company Ro launched an online GLP-1 supply tracker as an interactive tool to give patients real-time insights on GLP-1 drug shortages